|
1
|
Rugge M, Fassan M and Graham DY:
Epidemiology of gastric cancerGastric Cancer. Strong V: Springer;
Cham: pp. 23–34. 2015, View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Basile DP and Yoder MC: Circulating and
tissue resident endothelial progenitor cells. J Cell Physiol.
229:10–16. 2014.PubMed/NCBI
|
|
6
|
Ishige-Wada M, Kwon SM, Eguchi M, Hozumi
K, Iwaguro H, Matsumoto T, Fukuda N, Mugishima H, Masuda H and
Asahara T: Jagged-1 signaling in the bone marrow microenvironment
promotes endothelial progenitor cell expansion and commitment of
CD133+ human cord blood cells for postnatal vasculogenesis. PLoS
One. 11:e01666602016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salven P, Mustjoki S, Alitalo R, Alitalo K
and Rafii S: VEGFR-3 and CD133 identify a population of CD34+
lymphatic/vascular endothelial precursor cells. Blood. 101:168–172.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Folkman J, Browder T and Palmblad J:
Angiogenesis research: Guidelines for translation to clinical
application. Thromb Haemost. 86:23–33. 2001.PubMed/NCBI
|
|
9
|
Koch S, van Meeteren LA, Morin E, Testini
C, Weström S, Björkelund H, Le Jan S, Adler J, Berger P and
Claesson-Welsh L: NRP1 presented in trans to the endothelium
arrests VEGFR2 endocytosis, preventing angiogenic signaling and
tumor initiation. Dev Cell. 28:633–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kushner EJ and Bautch VL: Building blood
vessels in development and disease. Curr Opin Hematol. 20:231–236.
2013.PubMed/NCBI
|
|
11
|
Szala S and Jarosz M: Tumor blood vessels.
Postepy Hig Med Dosw (Online). 65:437–446. 2011.(In Polish).
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferrara N and Davis-Smyth T: The biology
of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Olson TA, Mohanraj D, Carson LF and
Ramakrishnan S: Vascular permeability factor gene expression in
normal and neoplastic human ovaries. Cancer Res. 54:276–280.
1994.PubMed/NCBI
|
|
14
|
Brown LF, Berse B, Jackman RW, Tognazzi K,
Manseau EJ, Senger DR and Dvorak HF: Expression of vascular
permeability factor (vascular endothelial growth factor) and its
receptors in adenocarcinomas of the gastrointestinal tract. Cancer
Res. 53:4727–4735. 1993.PubMed/NCBI
|
|
15
|
Joseph IB, Nelson JB, Denmeade SR and
Isaacs JT: Androgens regulate vascular endothelial growth factor
content in normal and malignant prostatic tissue. Clin Cancer Res.
3:2507–2511. 1997.PubMed/NCBI
|
|
16
|
Takahashi Y, Kitadai Y, Bucana CD, Cleary
KR and Ellis LM: Expression of vascular endothelial growth factor
and its receptor, KDR, correlates with vascularity, metastasis, and
proliferation of human colon cancer. Cancer Res. 55:3964–3968.
1995.PubMed/NCBI
|
|
17
|
Salven P, Ruotsalainen T, Mattson K and
Joensuu H: High pre-treatment serum level of vascular endothelial
growth factor (VEGF) is associated with poor outcome in small-cell
lung cancer. Int J Cancer. 79:144–146. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weidner N: Intratumor microvessel density
as a prognostic factor in cancer. Am J Pathol. 147:9–19.
1995.PubMed/NCBI
|
|
19
|
Joo HJ, Oh DK, Kim YS, Lee KB and Kim SJ:
Increased expression of caveolin-1 and microvessel density
correlates with metastasis and poor prognosis in clear cell renal
cell carcinoma. BJU Int. 93:291–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cavallaro U and Christofori G: Molecular
mechanisms of tumor angiogenesis and tumor progression. J
Neurooncol. 50:63–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Erenoglu C, Akin ML, Uluutku H, Tezcan L,
Yildirim S and Batkin A: Angiogenesis predicts poor prognosis in
gastric carcinoma. Dig Surg. 17:581–586. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kido S, Kitadai Y, Hattori N, Haruma K,
Kido T, Ohta M, Tanaka S, Yoshihara M, Sumii K, Ohmoto Y and
Chayama K: Interleukin 8 and vascular endothelial growth
factor-prognostic factors in human gastric carcinomas? Eur J
Cancer. 37:1482–1487. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wittekind C, Compton CC, Greene FL and
Sobin LH: TNM residual tumor classification revisited. Cancer.
94:2511–2516. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
An FQ, Matsuda M, Fujii H and Matsumoto Y:
Expression of vascular endothelial growth factor in surgical
specimens of hepatocellular carcinoma. J Cancer Res Clin Oncol.
126:153–160. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Weidner N: Intratumor microvessel density
as a prognostic factor in cancer. Am J Pathol. 147:9–19.
1995.PubMed/NCBI
|
|
26
|
Duda DG, Cohen KS, Scadden DT and Jain RK:
A protocol for phenotypic detection and enumeration of circulating
endothelial cells and circulating progenitor cells in human blood.
Nat Protoc. 2:805–810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim HK, Song KS, Kim HO, Chung JH, Lee KR,
Lee YJ, Lee DH, Lee ES, Kim HK, Ryu KW and Bae JM: Circulating
numbers of endothelial progenitor cells in patients with gastric
and breast cancer. Cancer Lett. 198:83–88. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ahn JB, Rha SY, Shin SJ, Jeung HC, Kim TS,
Zhang X, Park KH, Noh SH, Roh JK and Chung HC: Circulating
endothelial progenitor cells (EPC) for tumor vasculogenesis in
gastric cancer patients. Cancer Lett. 288:124–132. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li BJ, Cao FF, Xu LM, Nie ZH, Wei TX,
Zhang LG and Zhang DH: Endothelial progenitor cells and endothelial
cells in gastric cancer. Shanghai Med J. 34:467–469. 2011.(In
Chinese).
|
|
30
|
Folkman J, Browder T and Palmblad J:
Angiogenesis research: Guidelines for translation to clinical
application. Thromb Haemost. 86:23–33. 2001.PubMed/NCBI
|
|
31
|
Asahara T, Murohara T, Sullivan A, Silver
M, van der Zee R, Li T, Witzenbichler B, Schatteman G and Isner JM:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin H, Aiyer A, Su J, Borgstrom P, Stupack
D, Friedlander M and Varner J: A homing mechanism for bone
marrow-derived progenitor cell recruitment to the neovasculature. J
Clin Invest. 116:652–662. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Francavilla C, Maddaluno L and Cavallaro
U: The functional role of cell adhesion molecules in tumor
angiogenesis. Semin Cancer Biol. 19:298–309. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chakroborty D, Sarkar C, Basu B, Dasgupta
PS and Basu S: Catecholamines regulate tumor angiogenesis. Cancer
Res. 69:3727–3730. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Niwa H, Tsuneyama K and Takano Y: Expressions of MMP-2,
MMP-9 and VEGF are closely linked to growth, invasion, metastasis
and angiogenesis of gastric carcinoma. Anticancer Res,.
26:3579–3583. 2006.
|
|
36
|
Yang B, Gu W, Peng B, Xu Y, Liu M, Che J,
Geng J and Zheng J: High level of circulating endothelial
progenitor cells positively correlates with serum vascular
endothelial growth factor in patients with renal cell carcinoma. J
Urol. 188:2055–2061. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maeda R, Ishii G, Ito M, Hishida T,
Yoshida J, Nishimura M, Haga H, Nagai K and Ochiai A: Number of
circulating endothelial progenitor cells and intratumoral
microvessel density in non-small cell lung cancer patients:
Differences in angiogenic status between adenocarcinoma histologic
subtypes. J Thorac Oncol. 7:503–511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tsuchiya K, Hida K, Hida Y, Muraki C, Ohga
N, Akino T, Kondo T, Miseki T, Nakagawa K, Shindoh M, et al:
Adrenomedullin antagonist suppresses tumor formation in renal cell
carcinoma through inhibitory effects on tumor endothelial cells and
endothelial progenitor mobilization. Int J Oncol. 36:1379–1386.
2010.PubMed/NCBI
|
